CXCR4 and cancer: Along these lines, Xie et al. [128] developed PCX polymers from either AMD3100 or novel CXCR4-inhibiting monocyclam inhibitors that, besides affecting CXCR4/CXCL12 axis, introduce nucleic acids into the cancer cells to enhance the anticancer efficacy.